Integrated Analysis of Mutations, miRNA and mRNA Expression in Glioblastoma

Int J Gen Med. 2021 Nov 16;14:8281-8292. doi: 10.2147/IJGM.S336421. eCollection 2021.


Background: Glioblastoma multiforme (GBM) is a common, malignant brain tumor in adults, with a median survival of only 15-23 months. Organisms respond to disease stress through sophisticated mechanisms at the physiological, transcriptional and metabolic levels. However, the molecular regulatory networks responsible for occurrence, progression and recurrence of glioma have yet to be elucidated.

Methods: In this study, we sought to determine the cause of gliomas by developing an RNA-seq technique that analyzes mRNA and small RNA (sRNA) with the aim of discovering potential methods for precisely blocking key signaling pathways in occurrence, progression, and recurrence. The explication of mechanisms leading to GBM formation has become a feasible and promising new therapeutic method.

Results: GBM-associated genes were identified based on their expression during the disease stress response. Analysis of the inverse correlations between microRNAs (miRNAs) and target mRNAs revealed 43 mRNA-miRNA interactions during disease progression. BOC-SMO and BOC-RAS were found to promote the malignant progression of glioma. A total of 3088 differentially expressed genes were identified as involved in several biological processes, such as amino acid metabolism, protein transport associated with immune response, cell proliferation, and cell apoptosis. Fifteen miRNAs were also identified as being differentially expressed in GBM and control groups.

Conclusion: The results of this study provide an important foundation for understanding the pathogenesis of glioma and discovering new therapeutic targets.

Keywords: glioblastoma multiforme; miRNA; transcriptome.

Grant support

This study was funded by grants from the Science and Technology Planning Project of Hohhot, Inner Mongolia (No.2019-1-5).